Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — February 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 10, 2026
Sale
Shares
12,101
Price
$5.36
Total Value
$64.86K
Shares Held After
677,621
% of Holdings
1.8%
Feb 10, 2026
Sale
Shares
752
Price
$13.79
Total Value
$10.37K
Shares Held After
26,597
% of Holdings
2.7%

Schrödinger, Inc. (SDGR)

Lorton Kenneth Patrick — EVP, CTO & COO, Software
Feb 10, 2026
Sale
Shares
925
Price
$13.73
Total Value
$12.70K
Shares Held After
52,651
% of Holdings
1.7%

Schrödinger, Inc. (SDGR)

Tran Yvonne — EVP, CLO & CPO
Feb 10, 2026
Sale
Shares
776
Price
$13.80
Total Value
$10.71K
Shares Held After
22,859
% of Holdings
3.3%
Feb 10, 2026
Sale
Shares
91
Price
$276.79
Total Value
$25.19K
Shares Held After
2,696
% of Holdings
3.3%
Feb 10, 2026
Purchase
Shares
2,434
Price
$10.27
Total Value
$25.00K
Shares Held After
582,072
% of Holdings
0.4%

Lyell Immunopharma, Inc. (LYEL)

Bulis Veronica Sanchez — VP, Corporate Controller
Feb 10, 2026
Sale
Shares
254
Price
$23.12
Total Value
$5.87K
Shares Held After
15,637
% of Holdings
1.6%

Lyell Immunopharma, Inc. (LYEL)

Lee Gary K. — Chief Scientific Officer
Feb 10, 2026
Sale
Shares
147
Price
$23.12
Total Value
$3.40K
Shares Held After
18,609
% of Holdings
0.8%

Lyell Immunopharma, Inc. (LYEL)

Hill Stephen J. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
109
Price
$23.12
Total Value
$2.52K
Shares Held After
19,031
% of Holdings
0.6%
Feb 10, 2026
Sale
Shares
438
Price
$23.12
Total Value
$10.13K
Shares Held After
81,721
% of Holdings
0.5%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 10, 2026
Sale
Shares
20,000
Price
$23.52
Total Value
$470.40K
Shares Held After
43,298
% of Holdings
31.6%

Fortrea Holdings Inc. (FTRE)

Morais Mark A. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
590
Price
$14.11
Total Value
$8.32K
Shares Held After
58,052
% of Holdings
1.0%

Fortrea Holdings Inc. (FTRE)

Morais Mark A. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
589
Price
$13.65
Total Value
$8.04K
Shares Held After
58,642
% of Holdings
1.0%

Fortrea Holdings Inc. (FTRE)

Mcconnell Jill G. — Chief Financial Officer
Feb 10, 2026
Sale
Shares
441
Price
$14.11
Total Value
$6.22K
Shares Held After
59,574
% of Holdings
0.7%

Fortrea Holdings Inc. (FTRE)

Mcconnell Jill G. — Chief Financial Officer
Feb 10, 2026
Sale
Shares
440
Price
$13.65
Total Value
$6.01K
Shares Held After
60,015
% of Holdings
0.7%

BIODESIX INC (BDSX)

Pestano Gary Anthony — Chief Development Officer
Feb 10, 2026
Sale
Shares
540
Price
$10.08
Total Value
$5.45K
Shares Held After
9,387
% of Holdings
5.4%

BIODESIX INC (BDSX)

Hutton Scott — Director
Feb 10, 2026
Sale
Shares
3,559
Price
$10.08
Total Value
$35.89K
Shares Held After
45,413
% of Holdings
7.3%

BIODESIX INC (BDSX)

O'Kane Kieran — Chief Commercial Officer
Feb 10, 2026
Sale
Shares
584
Price
$10.08
Total Value
$5.89K
Shares Held After
8,885
% of Holdings
6.2%

BIODESIX INC (BDSX)

Cowie Robin Harper — CFO, Sec'y & Treasurer
Feb 10, 2026
Sale
Shares
941
Price
$10.08
Total Value
$9.49K
Shares Held After
15,297
% of Holdings
5.8%

BIODESIX INC (BDSX)

Vazquez Chris — Chief Accounting Officer
Feb 10, 2026
Sale
Shares
101
Price
$10.08
Total Value
$1.02K
Shares Held After
1,234
% of Holdings
7.6%
Feb 10, 2026
Sale
Shares
7,020
Price
$52.17
Total Value
$366.25K
Shares Held After
64,944
% of Holdings
9.8%
Feb 10, 2026
Sale
Shares
50,994
Price
$51.76
Total Value
$2.64M
Shares Held After
71,964
% of Holdings
41.5%

Tectonic Therapeutic, Inc. (TECX)

Lochner Daniel — Chief Financial Officer
Feb 10, 2026
Purchase
Shares
6,000
Price
$21.61
Total Value
$129.66K
Shares Held After
32,044
% of Holdings
18.7%

INTUITIVE SURGICAL INC (ISRG)

Curet Myriam — EVP & Chief Medical Officer
Feb 10, 2026
Sale
Shares
105
Price
$494.65
Total Value
$51.94K
Shares Held After
830
% of Holdings
11.2%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
40
Price
$650.32
Total Value
$26.01K
Shares Held After
9,823
% of Holdings
0.4%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
2,809
Price
$649.26
Total Value
$1.82M
Shares Held After
9,863
% of Holdings
22.2%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
966
Price
$648.78
Total Value
$626.72K
Shares Held After
12,672
% of Holdings
7.1%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
1,060
Price
$647.21
Total Value
$686.04K
Shares Held After
13,638
% of Holdings
7.2%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
2,782
Price
$646.23
Total Value
$1.80M
Shares Held After
14,698
% of Holdings
15.9%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
2,161
Price
$645.25
Total Value
$1.39M
Shares Held After
17,480
% of Holdings
11.0%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
397
Price
$644.02
Total Value
$255.67K
Shares Held After
19,641
% of Holdings
2.0%

IDEXX LABORATORIES INC /DE (IDXX)

FENNELL GEORGE — Executive Vice President
Feb 10, 2026
Sale
Shares
1,130
Price
$643.00
Total Value
$726.59K
Shares Held After
20,038
% of Holdings
5.3%

Envista Holdings Corp (NVST)

Reis Mischa — SVP, Strategy & Bus. Dev.
Feb 10, 2026
Sale
Shares
5,634
Price
$30.00
Total Value
$169.02K
Shares Held After
32,382
% of Holdings
14.8%

Envista Holdings Corp (NVST)

Reis Mischa — SVP, Strategy & Bus. Dev.
Feb 10, 2026
Sale
Shares
4,041
Price
$30.00
Total Value
$121.23K
Shares Held After
32,382
% of Holdings
11.1%

Voyager Therapeutics, Inc. (VYGR)

Carter Todd Alfred — Chief Scientific Officer
Feb 10, 2026
Sale
Shares
3,525
Price
$3.85
Total Value
$13.57K
Shares Held After
153,193
% of Holdings
2.2%
Feb 10, 2026
Sale
Shares
12,192
Price
$3.78
Total Value
$46.09K
Shares Held After
509,989
% of Holdings
2.3%
Feb 10, 2026
Sale
Shares
4,569
Price
$3.85
Total Value
$17.59K
Shares Held After
210,078
% of Holdings
2.1%

Mettler-Toledo International Inc. (MTD)

Vadala Shawn — Chief Financial Officer
Feb 10, 2026
Sale
Shares
800
Price
$1,410.12
Total Value
$1.13M
Shares Held After
5,288
% of Holdings
13.1%

APTARGROUP, INC. (ATR)

Prieur Marc — Segment President
Feb 10, 2026
Sale
Shares
2,000
Price
$137.81
Total Value
$275.62K
Shares Held After
13,745
% of Holdings
12.7%

Entera Bio Ltd. (ENTX)

Germano Geno J — Director
Feb 10, 2026
Purchase
Shares
20,000
Price
$1.49
Total Value
$29.80K

Entera Bio Ltd. (ENTX)

Taitel Haya — Director
Feb 10, 2026
Purchase
Shares
7,500
Price
$1.48
Total Value
$11.10K

Alignment Healthcare, Inc. (ALHC)

Wagner Andreas P. — Chief Human Resources Officer
Feb 10, 2026
Sale
Shares
22,238
Price
$20.47
Total Value
$455.21K
Shares Held After
169,805
% of Holdings
11.6%
Feb 10, 2026
Sale
Shares
180,000
Price
$20.49
Total Value
$3.69M
Shares Held After
2,652,641
% of Holdings
6.4%
Feb 10, 2026
Sale
Shares
6,894
Price
$2.42
Total Value
$16.70K
Shares Held After
146,506
% of Holdings
4.5%
Feb 10, 2026
Sale
Shares
22,562
Price
$27.46
Total Value
$619.55K
Shares Held After
591,656
% of Holdings
3.7%

Encompass Health Corp (EHC)

Tuer Patrick William — EVP, Chief Operating Officer
Feb 10, 2026
Sale
Shares
2,804
Price
$107.62
Total Value
$301.77K
Shares Held After
16,042
% of Holdings
14.9%

Merck & Co., Inc. (MRK)

Li Dean Y — Executive VP & President, MRL
Feb 10, 2026
Sale
Shares
10,235
Price
$117.52
Total Value
$1.20M
Shares Held After
92,035
% of Holdings
10.0%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Feb 10, 2026
Purchase
Shares
1,000
Price
$1.46
Total Value
$1.46K
Shares Held After
116,190
% of Holdings
0.9%
Feb 9, 2026
Purchase
Shares
4,800
Price
$9.96
Total Value
$47.82K
Shares Held After
161,757
% of Holdings
3.0%

Wave Life Sciences Ltd. (WVE)

Vargeese Chandra — Chief Technology Officer, Head of Platform Discovery Sciences
Feb 9, 2026
Sale
Shares
3,228
Price
$13.45
Total Value
$43.42K
Shares Held After
408,246
% of Holdings
0.8%
Version: v26.3.29